Authors:
Trillet-Lenoir, V
Lotz, JP
Le Cesne, A
Roy, P
Edouard, A
Citation: V. Trillet-lenoir et al., Reflexions from the experience of the French CLEOPATRE program and concerns about the status of clinical research on small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 303-307
Authors:
Zelek, L
Barthier, S
Riofrio, M
Fizazi, K
Rixe, O
Delord, JP
Le Cesne, A
Spielmann, M
Citation: L. Zelek et al., Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma, CANCER, 92(9), 2001, pp. 2267-2272
Authors:
Blay, JY
Le Cesne, A
Blanc-Vincent, MP
Fervers, B
Latour, JF
Philip, T
Citation: Jy. Blay et al., Standards, Options and Recommendations for the use of hematopoietic growthfactors in cancerology, PRESSE MED, 29(36), 2000, pp. 2004-2008
Authors:
Le Cesne, A
Judson, I
Crowther, D
Rodenhuis, S
Keizer, HJ
Van Hoesel, Q
Blay, JY
Frisch, J
Van Glabbeke, M
Hermans, C
Van Oosterom, A
Tursz, T
Verweij, J
Citation: A. Le Cesne et al., Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group, J CL ONCOL, 18(14), 2000, pp. 2676-2684
Authors:
Le Cesne, A
Vassal, G
Farace, F
Spielmann, M
Le Chevalier, T
Angevin, E
Valteau-Couanet, D
Fizazi, K
Cojean, I
Llombard, A
Tursz, T
Escudier, B
Citation: A. Le Cesne et al., Combination interleukin-2 and doxorubicin in advanced adult solid tumors: Circumvention of doxorubicin resistance in soft-tissue sarcoma?, J IMMUNOTH, 22(3), 1999, pp. 268-277
Authors:
Merimsky, O
Le Chevalier, T
Missenard, G
Lepechoux, C
Cojean-Zelek, I
Mesurolle, B
Le Cesne, A
Citation: O. Merimsky et al., Management of cancer in pregnancy: A case of Ewing's sarcoma of the pelvisin the third trimester, ANN ONCOL, 10(3), 1999, pp. 345-350
Authors:
Spielmann, M
Llombart, A
Zelek, L
Sverdlin, R
Rixe, O
Le Cesne, A
Citation: M. Spielmann et al., Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer, ANN ONCOL, 10(12), 1999, pp. 1457-1460
Authors:
Ray-Coquard, I
Le Cesne, A
Rubio, MT
Mermet, J
Maugard, C
Ravaud, A
Chevreau, C
Sebban, C
Bachelot, T
Biron, P
Blay, JY
Citation: I. Ray-coquard et al., Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens, J CL ONCOL, 17(9), 1999, pp. 2840-2846
Authors:
Le Pechoux, C
Le Deley, MC
Delaloge, S
Lartigau, E
Levy-Piedbois, C
Bonvalot, S
Le Cesne, A
Missenard, G
Terrier, P
Vanel, D
Genin, J
Fontaine, F
Citation: C. Le Pechoux et al., Postoperative radiotherapy in the management of adult soft tissue sarcoma of the extremities: Results with two different total dose, fractionation, and overall treatment time schedules, INT J RAD O, 44(4), 1999, pp. 879-886
Authors:
Fizazi, K
Dohollou, N
Blay, JY
Guerin, S
Le Cesne, A
Andre, F
Pouillart, P
Tursz, T
Bui, NB
Citation: K. Fizazi et al., Ewing's family of tumors in adults: Multivariate analysis of survival and long-term results of multimodality therapy in 182 patients, J CL ONCOL, 16(12), 1998, pp. 3736-3743